Ganetespib: research and clinical development

by Jhaveri, Komal, Modi, Shanu
Published in Onco Targets Ther (2015)

HER2 breast cancer therapies: a review

by Murphy, Conleth G, Modi, Shanu
Published 2009

Targeting the cyclin D–cyclin-dependent kinase (CDK)4/6–retinoblastoma pathway with selective CDK 4/6 inhibitors in hormone receptor-positive breast cancer: rationale, current stat...

by Spring, Laura, Bardia, Aditya, Modi, Shanu
Published in Discov Med (2016)

Unlocking the potential of antibody–drug conjugates for cancer therapy

by Drago, Joshua Z., Modi, Shanu, Chandarlapaty, Sarat
Published in Nat Rev Clin Oncol (2021)

Advances in the clinical development of heat shock protein 90 (Hsp90) inhibitors in cancers

by Jhaveri, Komal, Taldone, Tony, Modi, Shanu, Chiosis, Gabriela
Published 2011

Advances in the discovery and development of heat-shock protein 90 inhibitors for cancer treatment

by Patel, Hardik J, Modi, Shanu, Chiosis, Gabriela, Taldone, Tony
Published 2011

Chaperome heterogeneity and its implications for cancer study and treatment

by Wang, Tai, Rodina, Anna, Dunphy, Mark P., Corben, Adriana, Modi, Shanu, Guzman, Monica L., Gewirth, Daniel T., Chiosis, Gabriela
Published in J Biol Chem (2019)

Ex Vivo Treatment Response of Primary Tumors and/or Associated Metastases for Preclinical and Clinical Development of Therapeutics

by Corben, Adriana D., Uddin, Mohammad M., Crawford, Brooke, Farooq, Mohammad, Modi, Shanu, Gerecitano, John, Chiosis, Gabriela, Alpaugh, Mary L.
Published in J Vis Exp (2014)

Endocrine Therapy–Induced Alopecia in Patients With Breast Cancer

by Freites-Martinez, Azael, Shapiro, Jerry, Chan, Donald, Fornier, Monica, Modi, Shanu, Gajria, Devika, Dusza, Stephen, Goldfarb, Shari, Lacouture, Mario E.
Published in JAMA Dermatol (2018)

Phase 1b/2a study of trastuzumab emtansine (T-DM1), paclitaxel, and pertuzumab in HER2-positive metastatic breast cancer

by Krop, Ian E., Modi, Shanu, LoRusso, Patricia M., Pegram, Mark, Guardino, Ellie, Althaus, Betsy, Lu, Dan, Strasak, Alexander, Elias, Anthony
Published in Breast Cancer Res (2016)

The Effect of Molecular Subtype and Residual Disease on Locoregional Recurrence in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy and Postmastectomy Radiation

by Yang, T. Jonathan, Morrow, Monica, Modi, Shanu, Zhang, Zhigang, Krause, Kate, Siu, Chun, McCormick, Beryl, Powell, Simon N., Ho, Alice Y.
Published in Ann Surg Oncol (2015)

A multicenter trial evaluating retaspimycin HCL (IPI-504) plus trastuzumab in patients with advanced or metastatic HER2-positive breast cancer

by Modi, Shanu, Saura, Cristina, Henderson, Charles, Lin, Nancy U., Mahtani, Reshma, Goddard, Jill, Rodenas, Eduardo, Hudis, Clifford, O’Shaughnessy, Joyce, Baselga, Jose
Published 2013

Phase II Study of Weekly Paclitaxel with Trastuzumab and Pertuzumab in Patients with Human Epidermal Growth Receptor 2 Overexpressing Metastatic Breast Cancer: 5‐Year Follow‐up

by Wang, Rui, Smyth, Lillian M., Iyengar, Neil, Chandarlapaty, Sarat, Modi, Shanu, Jochelson, Maxine, Patil, Sujata, Norton, Larry, Hudis, Clifford A., Dang, Chau T.
Published in Oncologist (2019)

Frequent mutational activation of the PI3K-AKT pathway in trastuzumab-resistant breast cancer

by Chandarlapaty, Sarat, Sakr, Rita A., Giri, Dilip, Patil, Sujata, Heguy, Adriana, Morrow, Monica, Modi, Shanu, Norton, Larry, Rosen, Neal, Hudis, Clifford, King, Tari A.
Published 2012

Increased levels of urinary PGE-M, a biomarker of inflammation, occur in association with obesity, aging and lung metastases in patients with breast cancer

by Morris, Patrick G., Zhou, Xi Kathy, Milne, Ginger L., Goldstein, Daniel, Hawks, Laura C., Dang, Chau T., Modi, Shanu, Fornier, Monica N., Hudis, Clifford A., Dannenberg, Andrew J.
Published 2013

A Phase I study of alpelisib in combination with trastuzumab and LJM716 in patients with PIK3CA-mutated HER2-positive metastatic breast cancer

by Jhaveri, Komal, Drago, Joshua Z., Shah, Payal Deepak, Wang, Rui, Pareja, Fresia, Ratzon, Fanni, Iasonos, Alexia, Patil, Sujata, Rosen, Neal, Fornier, Monica N., Sklarin, Nancy T., Chandarlapaty, Sarat, Modi, Shanu
Published in Clin Cancer Res (2021)

Assessment of Quality of Life and Treatment Outcomes of Patients With Persistent Postchemotherapy Alopecia

by Freites-Martinez, Azael, Chan, Donald, Sibaud, Vincent, Shapiro, Jerry, Fabbrocini, Gabriella, Tosti, Antonella, Cho, Juhee, Goldfarb, Shari, Modi, Shanu, Gajria, Devika, Norton, Larry, Paus, Ralf, Cigler, Tessa, Lacouture, Mario E.
Published in JAMA Dermatol (2019)

Heat shock protein 90 inhibitors in the treatment of cancer: current status and future directions

by Jhaveri, Komal, Ochiana, Stefan O, Dunphy, Mark PS, Gerecitano, John F, Corben, Adriana D, Peter, Radu I, Janjigian, Yelena Y, Gomes-DaGama, Erica M, Koren, John, Modi, Shanu, Chiosis, Gabriela
Published 2014

Biomarkers that Predict Sensitivity to Heat Shock Protein 90 Inhibitors (HSP90i)

by Jhaveri, Komal, Chandarlapaty, Sarat, Iyengar, Neil, Morris, Patrick G., Corben, Adriana D, Patil, Sujata, Akram, Muzaffar, Towers, Russell, Sakr, Rita A, King, Tari A, Norton, Larry, Rosen, Neal, Hudis, Clifford, Modi, Shanu
Published in Clin Breast Cancer (2015)

Pilot study of (68)Ga-DOTA-F(ab′)(2)-trastuzumab in patients with breast cancer

by Beylergil, Volkan, Morris, Patrick G., Smith-Jones, Peter M., Modi, Shanu, Solit, David, Hudis, Clifford A., Lu, Yang, O’Donoghue, Joseph, Lyashchenko, Serge K., Carrasquillo, Jorge A., Larson, Steven M., Akhurst, Timothy J.
Published 2013